⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 1, 2024Open Access

Table S25 from CD46-Targeted Theranostics for PET and ²²⁵Ac-Radiopharmaceutical Therapy of Multiple Myeloma

Anju Wadhwa Sinan Wang Bonell Patiño-Escobar Anil P. Bidkar Kondapa Naidu Bobba Emily Chan Niranjan Meher Scott Bidlingmaier Yang Su Suchi Dhrona Huimin Geng Vishesh Sarin Henry F. VanBrocklin David M. Wilson Jiang He Li Zhang Veronica Steri Sandy W. Wong Thomas G. Martin Youngho Seo Bin Liu Arun P. Wiita Robert R. Flavell

View Full Paper

Ask AI

Bookmark

Share

Abstract

Table S25: [89Zr]Zr-DFO-YS5+ 50 fold YS5 %IA/g in the MM.1S systemic tumor model.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wadhwa et al. (2024) studied this question.

synapsesocial.com/papers/68e76734b6db6435876dca68 https://doi.org/10.1158/1078-0432.25324328.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S25 from CD46-Targeted Theranostics for PET and <sup>225</sup>Ac-Radiopharmaceutical Therapy of Multiple Myeloma2024
2Table S26 from CD46-Targeted Theranostics for PET and <sup>225</sup>Ac-Radiopharmaceutical Therapy of Multiple Myeloma2024
3Table S26 from CD46-Targeted Theranostics for PET and <sup>225</sup>Ac-Radiopharmaceutical Therapy of Multiple Myeloma2024
4Table S23 from CD46-Targeted Theranostics for PET and <sup>225</sup>Ac-Radiopharmaceutical Therapy of Multiple Myeloma2024
5Table S23 from CD46-Targeted Theranostics for PET and <sup>225</sup>Ac-Radiopharmaceutical Therapy of Multiple Myeloma2024